The trypanosome mRNA decapping enzyme ALPH1 prefers caps without m7G methylation and produces diphosphate RNA

Area of Science:

• Molecular Biology
• Biochemistry
• Parasitology

Background:

• Eukaryotic mRNA 5' ends are protected by the m7G cap, crucial for stability.
• mRNA decay involves decapping, typically by the nudix hydrolase DCP2.
• Kinetoplastida uniquely lack DCP2 and utilize the ALPH1 enzyme for decapping.

Purpose of the Study:

• To investigate the enzymatic properties of Trypanosoma brucei ALPH1.
• To compare ALPH1's substrate specificity and activity with the canonical DCP2 enzyme.
• To explore potential biotechnological applications of ALPH1.

Main Methods:

• Enzymatic assays using various cap analogues and RNA substrates.
• Analysis of ALPH1 structure-function relationships, including the role of its C-terminal domain.
• Comparison of ALPH1 activity in vitro with its essential role in cell viability.

Main Results:

• ALPH1 exhibits broad substrate specificity, accepting diverse cap types and analogues.
• ALPH1 demonstrates significantly faster turnover of non-methylated and cap-analogues compared to m7G-methylated substrates.
• Cleavage occurs at the β-γ pyrophosphate bond, yielding 5' diphosphate-RNA, with substrate preference determined by the catalytic domain.

Conclusions:

• ALPH1 possesses distinct enzymatic properties compared to DCP2, particularly in substrate specificity and cleavage site.
• The C-terminal domain is vital for ALPH1's cellular function and enhances in vitro activity, but not substrate preference.
• ALPH1's unique characteristics present intriguing differences from canonical decapping and suggest potential biotechnological uses.